United States Biotechnology & Medical Research

Vivakor Inc (VIVK)

Track

Track

Vivakor Inc. experienced significant insider trading activity during the second quarter of 2024. Chairman and CEO James H. Ballengee executed multiple purchase orders between April and June 2024, acquiring substantial equity stakes. No further transactions have been reported since June 3, 2024, placing all documented movements well beyond the three-month window.
Ticker: VIVK Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Vivakor Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Ballengee James H. Chairman, President, & CEO Executive Director Large shareholder
Transaction date
Purchase
Price
77.06
Quantity 88,178 -5.6%
Value US$4,705,746
3.5
Ballengee James H. Chairman, President, & CEO Executive Director Large shareholder
Transaction date
Purchase
Price
171.29
Quantity 63,551 -44.8%
Value US$1,921,809
3.5
Ballengee James H. Chairman, President, & CEO Executive Director Large shareholder
Transaction date
Purchase
Price
197.43
Quantity 28,184 -18.5%
Value US$4,746,284
3.5
Ballengee James H. Chairman, President, & CEO Executive Director Large shareholder
Transaction date
Purchase
Price
1.35
Quantity 42,098 +0.4%
Value US$56,731
3.5
Ballengee James H. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.37
Quantity 15,277 +1.1%
Value US$20,929
3.5
Ballengee James H. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.27
Quantity 41,381 +3.1%
Value US$52,554
3.5
Ballengee James H. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.29
Quantity 30,744 +2.4%
Value US$39,660
3.5
Ballengee James H. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.59
Quantity 47,500 +3.8%
Value US$75,525
3.5
Ballengee James H. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.59
Quantity 47,500 +3.8%
Value US$75,525
3.5
Ballengee James H. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.44
Quantity 54,500 +4.6%
Value US$78,480
3.5
Ballengee James H. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.44
Quantity 54,500 +4.6%
Value US$78,480
3.5
Ballengee James H. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.37
Quantity 138,000 +13.1%
Value US$189,060
3.5
Ballengee James H. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.12
Quantity 30,000 +2.9%
Value US$33,600
0.9
Nicosia Matthew Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 3,528
Value US$0
0.9
Nicosia Matthew Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
2.95
Quantity 320 +0.0%
Value US$944
0.9
Nicosia Matthew Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
2.95
Quantity 320 +0.0%
Value US$944
NFG, Inc. Large shareholder
Transaction date
Sale
Price
0.03
Quantity 825,000 -3.8%
Value US$24,750
NFG, Inc. Large shareholder
Transaction date
Purchase
Price
0.51
Quantity 3,500 +0.0%
Value US$1,768
NFG, Inc. Large shareholder
Transaction date
Purchase
Price
0.48
Quantity 3,500 +0.0%
Value US$1,680
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-06 2024-06-03 B Purchase
3.5
Ballengee James H.

Chairman, President, & CEO

Executive Director Large shareholder
88,178 -5.6%
77.06
US$4,705,746 		88,178 -5.6% 77.06 US$4,705,746
2024-08-06 2024-05-31 B Purchase
3.5
Ballengee James H.

Chairman, President, & CEO

Executive Director Large shareholder
63,551 -44.8%
171.29
US$1,921,809 		63,551 -44.8% 171.29 US$1,921,809
2024-08-06 2024-05-30 B Purchase
3.5
Ballengee James H.

Chairman, President, & CEO

Executive Director Large shareholder
28,184 -18.5%
197.43
US$4,746,284 		28,184 -18.5% 197.43 US$4,746,284
2024-08-06 2024-05-29 B Purchase
3.5
Ballengee James H.

Chairman, President, & CEO

Executive Director Large shareholder
42,098 +0.4%
1.35
US$56,731 		42,098 +0.4% 1.35 US$56,731
2024-05-29 2024-05-28 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
15,277 +1.1%
1.37
US$20,929 		15,277 +1.1% 1.37 US$20,929
2024-05-29 2024-05-24 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
41,381 +3.1%
1.27
US$52,554 		41,381 +3.1% 1.27 US$52,554
2024-05-29 2024-05-23 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
30,744 +2.4%
1.29
US$39,660 		30,744 +2.4% 1.29 US$39,660
2024-04-25 2024-04-24 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
47,500 +3.8%
1.59
US$75,525 		47,500 +3.8% 1.59 US$75,525
2024-04-25 2024-04-24 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
47,500 +3.8%
1.59
US$75,525 		47,500 +3.8% 1.59 US$75,525
2024-04-25 2024-04-23 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
54,500 +4.6%
1.44
US$78,480 		54,500 +4.6% 1.44 US$78,480
2024-04-25 2024-04-23 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
54,500 +4.6%
1.44
US$78,480 		54,500 +4.6% 1.44 US$78,480
2024-04-23 2024-04-22 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
138,000 +13.1%
1.37
US$189,060 		138,000 +13.1% 1.37 US$189,060
2024-04-23 2024-04-19 B Purchase
3.5
Ballengee James H.

Chief Executive Officer

Executive Director Large shareholder
30,000 +2.9%
1.12
US$33,600 		30,000 +2.9% 1.12 US$33,600
2022-02-25 2022-02-23 B Purchase
0.9
Nicosia Matthew

Chief Executive Officer

Executive Director Large shareholder
3,528
0.00
US$0 		3,528 0.00 US$0
2022-02-24 2022-02-17 B Purchase
0.9
Nicosia Matthew

Chief Executive Officer

Executive Director Large shareholder
320 +0.0%
2.95
US$944 		320 +0.0% 2.95 US$944
2022-02-18 2022-02-16 B Purchase
0.9
Nicosia Matthew

Chief Executive Officer

Executive Director Large shareholder
320 +0.0%
2.95
US$944 		320 +0.0% 2.95 US$944
2010-02-19 2010-02-17 S Sale NFG, Inc. Large shareholder
825,000 -3.8%
0.03
US$24,750 		825,000 -3.8% 0.03 US$24,750
2009-10-07 2009-10-07 B Purchase NFG, Inc. Large shareholder
3,500 +0.0%
0.51
US$1,768 		3,500 +0.0% 0.51 US$1,768
2009-10-07 2009-10-06 B Purchase NFG, Inc. Large shareholder
3,500 +0.0%
0.48
US$1,680 		3,500 +0.0% 0.48 US$1,680
Explore more

More insider trading research around Vivakor Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America